prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2144, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 867
2017
-
TP53 minor clones in clinical practice – case reports.
Year: 2017, type:
-
Tracking Low-Burden TP53-mutated subclones during CLL treatment and remission using ROR1 separation
Year: 2017, type: Conference abstract
-
Treatment with BCR inhibitors increases ROR1 expression in CLL cells
Year: 2017, type: Conference abstract
-
Usefulness of chemokine receptor CCR4 for diagnosis of cutaneous T-cell lymphomas by flow cytometry.
Year: 2017, type: Conference abstract
-
Úspěšná léčba ibrutinibem u pacientky s chronickou lymfocytární leukemií a nutností antiagregační terapie
Acta medicinae, year: 2017, volume: 6, edition: 3
-
Význam a využití NGS v diagnostice dědičných trombocytopenií.
Year: 2017, type: Conference abstract
-
Zkušenosti s léčbou ruxolitinibem u pacientu s myelofibrózou a pravou polycytemií na českých hematologických pracovištích
Transfuze a hematologie dnes, year: 2017, volume: 23, edition: 1
2016
-
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study
Leukemia, year: 2016, volume: 30, edition: 4, DOI
-
A prognostic model comprising only two biomarkers (IGHV mutational status and FISH-cytogenetics) separates patients with different prognosis and simplifies the CLL-IPI
Year: 2016, type: Conference abstract
-
Aktualizovaná doporučení pro diagnostiku a léčbu chronické lympfocytární leukémie (CLL) české CLL skupiny.
Year: 2016, type: Conference abstract